A triad of costimulatory molecules synergize to amplify T-cell activation

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5800-5807

  Hodge, James W ^a   Sabzevari, Helen ^a   Yafal, Alicia Gömez ^b   Gritz, Linda ^b   Lorenz, Matthias G O ^a   Schlom, Jeffrey ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Therion Biologics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; VIRUS VECTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; FEMALE; MOUSE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD58; ANTIGENS, CD80; APOPTOSIS; CARCINOEMBRYONIC ANTIGEN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POXVIRIDAE; RECOMBINATION, GENETIC; T-LYMPHOCYTES; TRANSGENES; TUMOR CELLS, CULTURED; VACCINIA;

EID: 0033571120     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hellstrom, K. E., Chen, L., and Hellstrom, I. Costimulation of T cell-mediated tumor immunity. Cancer Chemother. Pharmacol., 38: S40-S44, 1996.
2. + T lymphocytes. J. Immunol., 148: 1985-1992, 1992.
3. Guinan, E. C., Gribben, J. G., Boussiotis, V. A., Freeman, G. J., and Nadler, L. M. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor. Blood, 84: 3261-3282, 1994.
4. Wingren, A. G., Parra, E., Varga, M., Kalland, T., Sjogren, H. O., Hedlund, G., and Dohlsten, M. T-cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T-cell profiles. Crit. Rev. Immunol., 15: 235-253, 1995.
5. Parra, E., Wingren, A. G., Hedlund, G., Sjogren, H. O., Kalland, T., Sansom, D., and Dohlsten, M. Human naïve and memory T-helper cells display distinct adhesion properties to ICAM-1, LFA-3 and B7 molecules. Scand. J. Immunol., 38: 508-514, 1993.
6. Hellstrom, K. E., Hellstrom, I., Linsley, P., and Chen, L. On the role of costimulation in tumor immunity. Ann. NY Acad. Sci., 690: 225-230, 1993.
7. + T cells. J. Immunol., 158: 637-642, 1997.
8. Sperling, A. I., Auger, J. A., Ehst, B. D., Rulifson, I. C., Thompson, C. B., and Bluestone, J. A. CD28/B7 interactions deliver a unique signal to naïve T cells that regulates cell survival but not early proliferation. J. Immunol., 157: 3909-3917, 1996.
9. + T cells. ICAM-1 or B7-1 can costimulale naïve CD4 T-cell activation, but both are required for optimum response. J. Immunol., 155: 45-57, 1995.
10. Cavallo, F., Martin-Fontecha, A., Bellone, M., Heltai, S., Gatti, E., Tornaghi, P., Freschi, M., Fomi, G., Dellabona, P., and Casorati, G. Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol., 25: 1154-1162, 1995.
11. Kalus, R. M., Kantor, J. A., Gritz, L., Yafal, A. G., Mazzara, G. P., Schlom, J., and Hodge, J. W. The use of combination vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation. Vaccine, 17: 893-903, 1999.
12. Hodge, J. W., Abrams, S., Schlom, J., and Kantor, J. A Induction of anti-tumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res., 54: 5552-5555, 1994.
13. Uzendoski, K., Kantor, J. A., Abrams, S. I., Schlom, J., and Hodge, J. W. Construction and characterization of a recombinant vaccinia virus expressing murine interceltular adhesion molecule-1: induction and potentiation of anti-tumor responses. Hum. Gene Ther., 8: 851-860, 1997.
14. Lorenz, M. G. O., Kantor, J. A., Schlom, J., and Hodge, J. W. Induction of anti-tumor immunity elicited by recombinant vaccinia virus expressing murine leukocyte function associated antigen-3 (LFA-3). Hum. Gene Ther., 10: 623-631, 1999.
15. Jenkins, S., Gritz, L., Fedor, C. H., O'Neill, E. M., Cohen, L. K., and Panicali, D. L. Formation of lentivirus particles by mammalian cells infected with recombinant fowlpox virus. AIDS Res. Hum. Retroviruses, 7: 991-998, 1991.
16. Gritz, L., Destree, A., Cormier, N., Day, E., Stallard, V., Caiazzo, T., Mazzara, G., and Panicali, D. Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type I env. J. Virol., 64: 5948-5957, 1990.
17. Chakrabarti, S., Sisler, J. R., and Moss, B. Compact, synthetic, vaccinia virus early/late promoter for protein expression Biotechniques, 23: 1094-1097, 1997.
18. Perkus, M. E., Piccini, A., Lipinskas, B. R., and Paoletti, E. Recombinant vaccinia virus: immunization against multiple pathogens. Science (Washington DC), 229; 981-984, 1985.
19. Schmitt, J. F., and Stunnenberg, H. G. Sequence and transcriptional analysis of the vaccinia virus HindIII I fragment. J. Virol., 62: 1889-1897, 1988.
20. Venkatesan, S., Baroudy, B. M., and Moss, B. Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell, 25: 805-813, 1981.
21. Fox, B. A., Spiess, P. J., Kasid, A., Puri, R., Mule, J. J., Weber, J. S., and Rosenberg, S. A. In vitro and in vivo anti-tumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. J. Biol. Response Modif., 9: 499-511, 1990.
22. Hodge, J. W., McLaughlin, J. P., Abrams, S. I., Shupert, W. L., Schlom, J., and Kantor, J. A. The admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and anti-tumor immunity. Cancer Res., 55: 3598-3603, 1995.
23. + T-lymphocytes against tumor cells bearing mutated epitopes of K-ras p21. Eur. J. Immunol., 25: 2588-2597, 1995.
24. + cells of older lupus mice. Eur. J. Immunol., 27: 1901-1910, 1997.
25. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
26. Thomspon, J. A., Grunert, F., and Zimmerman, W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal., 5: 344-366, 1991.
27. Kass, E., Schlom, J., Thompson, J., Guadagni, F., and Greiner, J. W. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA-transgenic mice, by immunizing with a recombinant vaccinia-CEA virus. Cancer Res., 59: 676-683, 1999.
28. + T lymphocytes into Th1/Th2 effectors. Vaccine, 16: 1415-1419, 1998.
29. Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., and Thompson, C. B. CD28 costimulation can promote T-cell survival by enhancing the expression of Bel-XL. Immunity, 3: 87-98, 1995.
30. Robbins, P.F., Kantor, J. A., and Salgaller, M. Transduction and expression of the human carcinoembryonic antigen in a murine colon carcinoma cell line. Cancer Res., 51: 3657-3662, 1992.